1. Home
  2. VERU vs HFBL Comparison

VERU vs HFBL Comparison

Compare VERU & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.62

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Logo Home Federal Bancorp Inc. of Louisiana

HFBL

Home Federal Bancorp Inc. of Louisiana

N/A

Current Price

$19.24

Market Cap

41.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
HFBL
Founded
1971
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
41.6M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
VERU
HFBL
Price
$2.62
$19.24
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
65.5K
2.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.85%
EPS Growth
N/A
7.69
EPS
N/A
1.07
Revenue
$16,296,958.00
$1,303,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.69
Revenue Growth
N/A
17.49
52 Week Low
$0.36
$12.31
52 Week High
$4.59
$20.00

Technical Indicators

Market Signals
Indicator
VERU
HFBL
Relative Strength Index (RSI) 55.32 60.86
Support Level $2.15 $12.87
Resistance Level $2.77 $20.00
Average True Range (ATR) 0.16 0.23
MACD 0.02 -0.02
Stochastic Oscillator 79.17 100.00

Price Performance

Historical Comparison
VERU
HFBL

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

Share on Social Networks: